Vmbook Online ordering

Bio Rad Laboratories Inc

Sure, I can help you with that.

Bio-Rad Laboratories, Inc. is a publicly-traded company listed on the New York Stock Exchange (NYSE) under the ticker symbol BIO. The company was founded in 1952 and is headquartered in Hercules, California, USA.

Bio-Rad Laboratories is a global provider of life science research and clinical diagnostic products. The company develops, manufactures, and markets a range of products and solutions for the life science research, healthcare, and biotechnology markets.

Bio-Rad's products include reagents, apparatus, and instruments for research and clinical diagnostic applications. The company's product portfolio includes solutions for protein purification, cell culture, western blotting, PCR (polymerase chain reaction), qPCR (quantitative PCR), gene editing, and immunoassays. They also offer a range of instruments such as spectrophotometers, plate readers, and imaging systems.

Bio-Rad Laboratories has a strong focus on research and development, and invests a significant portion of its revenue into R&D activities. The company has a global presence, with subsidiaries and distributors in over 30 countries.

As of February 2023, Bio-Rad Laboratories has a market capitalization of around $12.8 billion USD. The company's stock has been steadily growing over the years, with a 5-year annual return of around 14%. The company has a strong track record of profitability and has consistently paid dividends to its shareholders.

In summary, Bio-Rad Laboratories is a well-established life science research and clinical diagnostic company with a global presence, a strong product portfolio, and a history of steady growth and profitability.